期刊文献+

氯氮平和利培酮对精神分裂症患者体质量的影响 被引量:7

Effects of clozapine and risperidone on body weight of schizophrenic patients
下载PDF
导出
摘要 目的:探讨氯氮平和利培酮对精神分裂症患者体质量(体重)的影响及相关因素。方法:选择符合国际疾病分类第10版(ICD-10)精神分裂症的诊断标准,空腹血糖正常,无严重躯体疾病,1周内未用任何抗精神病药的住院患者,共计65例,其中利培酮组32例,氯氮平组33例。两组患者于治疗前和治疗6周末分别做葡萄糖耐量试验,测空腹血胰岛素,测量体质量、身高,计算体质量指数(BMI),评定阳性与阴性症状量表(PANSS)。结果:①治疗后体质量增加者氯氮平组24例(占72.7%),利培酮组19例(占59.4%);氯氮平组体质量平均增加2.5kg,利培酮组1.4kg;②氯氮平组体质量增加与进食量增加、胰岛素水平增加和PANSS评分减分率相关(P<0·05),体质量增加者餐后1h血糖升高;③利培酮组体质量增加与年龄、病程显著相关(P<0·05),与基础BMI存在负相关倾向;④两组治疗后均出现糖耐量减低(IGT)和暂时诊断糖尿病(DM)。结论:氯氮平和利培酮均能导致体质量增加,体质量增加更易对糖代谢造成不良影响。 Objectlve:To detect the effect on body weight of schizophrenic patients by elozapine and risperidone and its related factors. Method:Inpatients who met the diagnostic criteria of schizophrenia in ICD-10, normal fasting blood glucose, without seriors somatic disease, and without any antipsychotic was used before 1 week were selected in this study. All of them were 65 cases: 32 cases in risperidone group and 33 cases in clozapine group. Glucose tolerance test was made before the treatment and 6 weeks after the treatment in both groups of patients. Fasting insulin level, body weight,body height,body mass index (BMI) and positive and negative symptoms seale(PANSS) were examined. Results: 1. Body weight increased after the treatment in clozpine group were 24 cases(72.7% )and 19 eases(59.4% ) in risperidone group. Net weight was increased 2.5 kg in clozapine group and 1.4 kg in risperidone group. 2. There was relationship among increasing of body weight and increasing of meal intake, increasing of insulin level and decreas- ing rate of PANSS (P 〈 0.05). If patients' body weight were increased,their blood glucose leval at 1 hour after the meal were increased also. 3. Increasing of body weight were significantly related with age and the course of disorder ( P 〈 0.05 ). There was negative relationship with BMI. 4. Glucose tolerance was decreased after the treatment and diagnosed to diabetes mellitus temporary in both groups. Conclusion: Both clozapine and risperidone can induce to increase body weight. This will make more disadventage effects on glucose metabolism.
出处 《临床精神医学杂志》 2006年第1期5-7,共3页 Journal of Clinical Psychiatry
基金 北京市重点扶持学科经费及首都医学发展科研基金资助(首都ZD199816)
关键词 精神分裂症 氯氮平 利培酮 体质量 葡萄糖耐量试验 schizophrenia clozapine risperidone body weight glucose tolorene test
  • 相关文献

参考文献17

  • 1Ananth J.Atypical antipsychotic induced weight gain:pathophysiology and management[J].Ann Clin Psychiatry,2004,16:75-85.
  • 2Lee E,Leung CM,Wong E.Atypical antipsychotics and weight gain in Chinese patients:a comparison of olanzapine and risperidone[J].J Clin Psychiatry,2004,65:864-866.
  • 3Citrome LL,Jaffe AB.Relationship of atypical antipsychotics with development of diabetes mellitus[J].Ann Pharmacother,2003,37:1849-1857.
  • 4Farver D.Weight gain and longterm complications with atypical antipsychotics[J].S D J Med,2001,54:11-12.
  • 5Wetterling T.Bodyweight gain with atypical antipsychotics.A comparative review[J].Drug Saf,2001,24:59-73.
  • 6Weiden PJ,Maekell JA,McDonnell DD.Obesity as a risk factor for antipsychotic noncompliance[J].Schizophr Res,2004,66:51-57.
  • 7Blin O,Micallef J.Antipsychotic-associated weight gain and clinical outcome parameters[J].J Clin Psychiatry,2001,62 (Suppl 7):11-21.
  • 8Hermida T.Weight gain associated with atypical antipsychotics[J].J Am Acad Child Adolesc Psychiatry,2002,41:1272-1273.
  • 9Fitzgerald PB.The relationship of changes in leptin,neuropeptide Y and reproductive hormones to antipsychotic induced weight gain[J].Hum Psychopharmacol,2003,18:551-557.
  • 10李国海,俞俊洪.瘦素与抗精神病药所致体重增加[J].临床精神医学杂志,2004,14(1):52-53. 被引量:7

二级参考文献22

  • 1[13]Baptista T, Lacruz A, Angeles F, et al. Endocrine and metabolic abnomal ities involved in obesity associated with typical antipsychotic drug admin istration[ J ]. Pharmacopsychiatry, 2001,34: 223-231.
  • 2[14]Friedman JM, Halassa JL. Leptin and the regulation of body weight in mammals[ J ]. Nature, 1998,22: 763-770.
  • 3[15]Sinha MK, Caro JF. Clinical aspects of leptin [ J ]. Vitam Horm, 1998,54:1-30.
  • 4[16]Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin [ J ]. Curr Opin Lipidol, 2002,13: 51-59.
  • 5[17]Kolaczynski JM, Nyce MR, Consuidine RV, et al. Acute and chronic ef fects of insulin on leptin production in human studies in vivo and iv vitro [J]. Diabetes, 1996,45: 699-701.
  • 6[1]Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue[ J]. Nature, 1994,372:423-425.
  • 7[2]Isse N, Ogawa Y, Tamura N, et al. Structural organization and chromosomal assignment of the human obese gene[J]. J Biol Chem, 1995,270: 27728-27733.
  • 8[3]Halassa JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene[ J]. Science, 1995,269:543- 546.
  • 9[4]Van Dijk G. The role of leptin in the regulation of energy balance and adiposity[ J]. J Neuroendocrinol,2001,13:913-921.
  • 10[5]Jequier E. Leptin signaling, adiposity, and energy balance[ J ]. Ann N YAcad Sci, 2002,967: 379-388.

共引文献24

同被引文献47

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部